AbbVie takes next step in Ukraine, donating all Russia profits to relief
Last month, AbbVie joined pharmas Novartis and Eli Lilly to distance themselves from Russia in light of that country’s aggression against Ukraine — by suspending its operations for their aesthetics products.
AbbVie said in a statement at the time that the pharma “has temporarily suspended operations for all our aesthetics products in Russia,” adding that the company has no manufacturing plants in the region and would continue to monitor their employees in Ukraine and the surrounding area.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.